MMP-2及其对心脏功能和结构的影响:在高血压中与炎症的相互作用
Thaís Ribeiro Vitorino1, Alejandro Ferraz do Prado2, Stefany Bruno de Assis Cau3
1Unit of Biotechnology, University of Ribeirao Preto, UNAERP, Brazil; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, UNICAMP, Brazil.
Biochemical pharmacology
|July 17, 2023
概括
高血压通过炎症导致心力衰竭. 准矩阵金属蛋白酶-2 (MMP-2) 可能减少高血压心脏病中的心脏损伤和炎症.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 高血压是心力衰竭发展的主要危险因素.
- 炎症细胞和细胞因子在心脏重塑和功能障碍中起着至关重要的作用.
- 心脏重塑涉及到细胞外矩阵金属蛋白酶 (MMPs) 的激活.
研究的目的:
- 审查矩阵金属蛋白酶-2 (MMP-2) 在高血压引起的心脏重塑和损伤中的作用.
- 探索涉及MMP-2调控中的细胞因子和炎症细胞的信号通路.
- 调查MMP-2和炎症在维持心脏功能中的相互作用.
主要方法:
- 临床前和临床研究的综述.
- 对调节MMP-2转录,分泌和激活的信号通路的分析.
- 探索MMP-2和炎症媒介之间的相互作用.
主要成果:
- 增加的MMP-2水平有助于心脏重塑和高血压中的损伤.
- 细胞因子和炎症细胞显著影响MMP-2活性.
- MMP-2和炎症表现出协调的作用,影响心脏循环.
结论:
- MMP-2是高血压相关心脏损伤的关键调解者.
- 准MMP-2为高血压心脏病提供了潜在的治疗策略.
- 专注于MMP-2的治疗干预可以减少炎症生物标志物和心脏损伤.
相关概念视频
Myocarditis I: Introduction
10
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
121
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
121
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Hypertension II: Pathophysiology
20
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
20


